Clinical Data Announces Renewed DNA Sequencing Contract with MRC
News Jun 06, 2006
The Company's Cogenics division (formerly Lark Technologies) is UK based provider of DNA sequencing to pharmaceutical, biotech and academic institutes with a long history of working with the MRC.
Paul Tomlin, Director of European Operations, said, "We are very pleased to continue our relationship with the MRC and are confident of meeting the needs of MRC scientists across all 35 UK sites."
"Cogenics has over 17 years experience with DNA sequencing and other molecular biology services and as such is uniquely positioned to provide the best customer experience possible and to serve the needs of the MRC."
Cogenics provides comprehensive pharmacogenomics and molecular services to the scientific community with six sites across North America and Europe employing over 200 experienced scientists and other professionals.
China is poised to introduce a new regulation on gene editing in humans. A draft of the country’s new civil code lists human genes and embryos in a section on personality rights to be protected. Experiments on genes in adults or embryos that endanger human health or violate ethical norms can accordingly be seen as a violation of a person’s fundamental rights.READ MORE